Free Newsletter
Biomedical researchers lobby against funding cuts
Some of the country's top biomedical researchers have been beating a path to Congress in an attempt to fend off deep cuts in research funds. Nobel Prize winner Roger D. Kornberg, for example, has been making the point that it was doubtful he could have done his groundbreaking work on the way DNA is copied in the current budgetary environment. "In the present climate especially, the funding decisions are ultraconservative," he told The Washington Post. "If the work that you propose to do isn't virtually certain of success, then it won't be funded." As a result, young scientists are steering away from research and big leaps promised in cancer, Alzheimer's and other diseases may never materialize.
- check out the UPI report on the protests
Related Article:
Institutions lament squeeze on federal research funds. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceBiotech Research email newsletter for FREE!
Be the first to comment